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Background: The MALDI (matrix-assisted laser desorption/ionization) Biotyper system for bacterial identification has
already been utilized in clinical microbiology laboratories as a successful clinical application of protoemics. However,
in cases of Nocardia, mass spectra suitable for MALDI Biotyper identification are often not obtained if such
specimens are processed like general bacteria. This problem is related to the insufficiencies in bacterial spectrum
databases that preclude accurate specimen identification. Here, we developed a bacterial processing method to
improve mass spectra from specimens of the genus Nocardia. In addition, with the new processing method, we
constructed a novel in-house bacterial database that combines a commercial database and mass spectra of
Nocardia strains from the Department of Clinical Laboratory at Chiba University Hospital (DCLC) and the Medical
Mycology Research Center at Chiba University (MMRC).
Results: The newly developed method (Nocardia Extraction Method at DCLC [NECLC]) based on ethanol-formic acid
extraction (EFAE) improved mass spectra obtained from Nocardia specimens. The Nocardia in-house database at
Chiba University Hospital (NDCUH) was then successfully validated. In brief, prior to introduction of the NECLC and
NDCUH, 10 of 64 (15.6%) clinical isolates were identified at the species level and 16 isolates (25.0%) could only be
identified at the genus level. In contrast, after the introduction, 58 isolates (90.6%) were identified at the species
level and 6 isolates (9.4%) were identified at the genus level.
Conclusions: The results of this study suggest that MALDI-TOF (time-of-flight) Biotyper system can identify Nocardia
accurately in a short time in combination with a simple processing method and an in-house database.
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Actinomycetes, which are pathogenic and infectious to
humans, include both aerobic and anaerobic bacteria;
representative of the former are bacteria of the genus Nocar-
dia, and representative of the latter include bacteria of the
genus Actinomyces [1]. Nocardiosis is an infection involving
bacteria of the genus Nocardia. These bacteria are often iso-
lated from immunocompromised patients taking immuno-
suppressants or steroids for the purpose of treating collagen* Correspondence: ZXA03460@nifty.ne.jp
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unless otherwise stated.disorders or organ transplantation, suggesting that nocardio-
sis is primarily an opportunistic infection; however, on rare
occasions it is seen in healthy individuals [2,3]. Pneumonia
can occur from inhalation of Nocardia, and entry through a
cut in the skin can cause a skin infection. Hematogenous dis-
semination to organs throughout the body can also occur;
for example, cerebral abscesses due to nocardiosis have been
reported. Among bacteria of the Nocardia genus,N. farcinica
and N. nova are the most frequently isolated, followed by N.
brasiliensis and N. cyriacigeorgica.
Because antimicrobial susceptibility and pathogen-
icity differ depending on the species of Nocardia [4],
from a clinical perspective, the results of bacterial identifi-
cation should be reported rapidly, similar to the minimuml. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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just the genus level but the species level as well is needed.
To distinguish between the genera of actinomycetes, ana-
lyses of the taxonomic and physicochemical properties of
the organism are necessary, including analyses of mycolic
acid and menaquinone and the sugars and amino acids
composing the cell wall. These physicochemical properties
can be used to identify species of the genus Nocardia [5].
However, identification based on physicochemical proper-
ties is time consuming, and the identification procedures
are complex. On the other hand, as with other bacteria,
classification of Nocardia based on the 16S rRNA se-
quence has been introduced [6] and has simplified species
identification, but employing this method in the laboratory
remains difficult in routine identification testing.
Recently, the MALDI Biotyper (Bruker Daltonics GmbH,
Leipzig, Germany) was developed as a new system for bac-
terial identification [7-9]. In this system, matrix-assisted
laser desorption/ionization–time-of-flight mass spectrometry
(MALDI-TOF MS) is used in combination with database
software. By collecting mass spectra of the bacteria and com-
paring these to mass spectra of various bacteria compiled in
a database and scoring the match, rapid identification of bac-
teria has become possible [10-12]. In our clinical laboratory,
we used MALDI-TOF MS to identify general bacteria iso-
lated from clinical samples and have reported a high identifi-
cation rate (91.7%) at the species level [7]. More recently, we
reported on direct application of MALDI-TOF mass spec-
trometry to cerebrospinal fluid for rapid pathogen identifica-
tion in a patient with bacterial meningitis [13]. However, in
the identification of acid-fast bacteria and actinomycetes such
as those of the genus Nocardia, spectra adequate for identifi-
cation cannot be obtained using only processes for general
bacteria due to the presence of aliphatic acids such as myco-
lic acid in the cell wall, and sometimes, mass spectra of suffi-
cient intensity for scoring Nocardia isolates cannot be
obtained at all [14]. In addition, data on only 37 isolates from
32 species of Nocardia have been compiled in the database
(Bruker Biotyper ver. 3.3.1.0 database), which is insufficient
from a practical perspective, and currently, species-level
identification is often difficult.
To resolve these problems and improve the precision of
Nocardia identification, we developed a new method for
bacterial extraction. We also created and evaluated an in-
house database using Nocardia strains stored at the Depart-
ment of Clinical Laboratory at Chiba University Hospital
(DCLC) and the Medical Mycology Research Center in
Chiba University (MMRC) and report our findings here.
Results
Comparison of the NECLC approach and conventional
extraction methods
We proposed a new method for Nocardia extraction
(NECLC). This method is based on the ethanol-formicacid extraction method (EFAE) (Figure 1A), with the
addition of silica beads as a component of the high-
temperature extraction method (HTEM) (Figure 1B) and
use of a 10-minute formic acid extraction time (Figure 1C).
Table 1 shows changes in the identification scores of 10
Nocardia isolates determined using the NECLC and EFAE
methods. Improved identification scores were seen with
the NECLC approach, and it became possible to collect
mass spectra for bacterial species for which it had previ-
ously not been possible. Representative improvement in
the spectra is shown in Figure 2. However, species-level
identification was still not optimal.Validation of the NDCUH
The Nocardia in-house database at Chiba University
Hospital (NDCUH) was constructed using the new ex-
traction method (NECLC) to process 192 Nocardia iso-
lates stored at the MMRC and generate mass spectra as
described in the “Methods” section. Results of the clus-
ter analysis were used for the construction of a spectra-
based dendrogram (Additional file 1: Figure S5). The
Nocardia strains were not divided into 2 clusters com-
prised of the manufacturer’s database strains and the
192 MMRC isolates; they appeared to be distributed
without extreme bias.
Next, we evaluated the NDCUH database. In brief,
mass spectra were generated for 64 Nocardia isolates
(Table 2, Additional file 2: Table S1), independent of the
isolates used to construct the database, and changes in
the mass spectra and identification scores before and
after introduction of the in-house database were com-
pared. The results of a comparison of N. nova and N.
elegans isolates are shown in Additional file 3: Figure S6,
and the results for 64 Nocardia isolates are summa-
rized in Table 3. In brief, prior to introduction of the
in-house database, 10 isolates (15.6%) were identified
at the species level and 16 isolates (25%) could only be
identified at the genus level. In contrast, identification
scores improved after introduction of the in-house
database, as 58 isolates (90.6%) were identified at the
species level and 6 isolates (9.4%) were identified to
the genus level only.Discussion
In the present study, we developed a bacterial processing
method (NECLC) and constructed a novel in-house bac-
terial database (NDCUH) that combines a commercial
database and mass spectra of Nocardia strains to im-
prove identification of Nocardia by MALDI-TOF MS.
The NECLC approach improved Nocardia identification
scores (Table 1), and use of the NDCUH database in
conjunction with the NECLC method was then success-
fully validated (Table 3).
Figure 1 (See legend on next page.)
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Figure 1 Comparison of conventional bacterial extraction methods and the newly developed Nocardia extraction method. Procedures
in conventional bacterial sample extraction methods (ethanol-formic acid extraction [EFAE] and high-temperature extraction [HTEM]) are shown
in (A) and (B), respectively. We propose a new Nocardia extraction method (Nocardia extraction method in Department of Clinical Laboratory at
Chiba University hospital; NECLC). This method is based on EFAE, incorporating an element of the HTEM (indicated in red in the figure) method,
with the further addition of a formic acid extraction time of 10 minutes (underlined) (C).
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cult in the past, is now possible thanks to the results of
a variety of studies [15-17]. Wauters et al. performed
rapid identification using 9 tests, including those involv-
ing biochemical properties and enzyme activity, and
achieved identification rates of ≥95% for 6 bacterial spe-
cies commonly isolated from clinical samples [18]. In
addition, in a study by Glupczynski et al. N. farcinica, N.
nova, N. cyriacigeorgica, N. abscessus, and N. brasiliensis
were identified based on the results of antimicrobial sus-
ceptibility testing of 12 species [19]. It is also now pos-
sible to identify Nocardia by molecular means, and in a
study by Conville et al., identification was performed by
16S rRNA genetic analysis [6].
At the MMRC, we typically identify Nocardia by
determining physicochemical properties and sensitivity to
antimicrobials [5]. Genetic analysis of 16S rRNA sequences
is also employed at the MMRC. At the clinical laboratory
of this hospital, the Mycology Center identifies Nocardia
isolated from clinical samples, but due to the particulars of
identification tests, it takes approximately 1 month for the
official identification results to be delivered, which is not
compatible with rapid identification.
Bacterial identification using MALDI-TOF MS was
developed to replace conventional identification tests.Table 1 Comparison of identification scores for specimens




Nocardia isolate Mean ± SD Mean ± SD
N. nova-2010/742 1.94 ± 0.06 2.11 ± 0.03 0.00008909***
N. nova-2011/258 1.89 ± 0.04 2.12 ± 0.04 0.00000340***
N. otitidiscaviarum-2010/435 1.94 ± 0.09 2.10 ± 0.06 0.00557253**
N. otitidiscaviarum-2012/744 1.68 ± 0.10 2.01 ± 0.10 0.00001193***
N. farcinica-2011/1341 1.27 ± 0.13 1.39 ± 0.08 0.02787181*
N. farcinica-2012/241 1.24 ± 0.08 1.37 ± 0.10 0.02223143*
N. elegans-2011/259 - 1.28 ± 0.15 #
N. elegans-2010/1158 1.22 ± 0.05 1.46 ± 0.10 0.00000972***
N. cyriacigeorgica-2011/531 - 1.33 ± 0.09 #
N. cyriacigeorgica-2012/1454 1.25 ± 0.10 1.40 ± 0.01 0.00209917**
Three colonies obtained from each of the various Nocardia isolates were
analyzed. Each colony was subjected to 3 independent extraction/MS runs,
and the identification scores obtained were compared statistically.
*: indicates isolate showing significant improvement (P < 0.05). **: P < 0.01,
***: P < 0.0001, #: indicates sufficient mass spectra for scoring could not be
obtained using the EFAE method.For the genus Nocardia, a study by Verroken et al.
[14] proposed a processing method that involved high-
temperature extraction and their in-house database con-
structed using 91 isolates from 11 Nocardia species. Re-
sults of verification of this method using 43 Nocardia
isolates from 9 species showed that before introduction
of their in-house database, 10 isolates (23%) were identi-
fied to the species level and 9 isolates to the genus level
(21%), whereas after introduction, 34 isolates (79%) were
identified to the species level and 4 isolates (9%) could
be identified only to the genus level due to improvement
in identification scores.
In the study of Verroken et al., a 1-hour pretreatment
process that includes 30 minutes of heat treatment was
required [14]. The new NECLC approach we propose in
this study to replace the EFAE and HTEM methods
simplifies the Nocardia extraction process and eliminates
the requirement for high temperature. As a result, Nocardia
identification can now be achieved in 30 minutes. We also
attempted to enhance the database by incorporating the
mass spectra of a variety of bacterial species stored at the
Mycology Center. Identification scores improved after
introduction of the in-house database, as 58 isolates
(90.6%) were identified at the species level and 6 isolates
(9.4%) were identified to the genus level only. It is
reported that silica beads are effective tools to extract
bacterial proteins from acid-fast bacteria [20]. Also, the
NECLC method employing silica beads was effective to
process Nocardia (Additional file 4: Figure S1). Using the
proposed NECLC approach and the 192 Nocardia isolates
from the MMRC, we were able to construct a enriched
in-house database (NDCUH), which has contributed to
improving identification scores of Nocardia species
(Table 1, Additional file 3: Figure S6). There were several
isolates, however, that could be identified only at the
genus level and not the species level. Refinements in the
pretreatment procedures and database will be necessary to
further improve identification of Nocardia.
Conclusions
Our findings suggest that by using the MALDI-TOF Biotyper
MS system along with our new method for bacterial
extraction (NECLC) in combination with the in-house data-
base we constructed, the majority of Nocardia clinical iso-
lates can now be simply and accurately identified in a short
period of time. As a result, the identification rate reached
90.6% at the species level and 9.4% at the genus level.
Figure 2 Representative improvement in spectra of a N. otitidiscaviarum isolate by employing the NELCL method. Representative spectra
and identification scores from analysis of a N. otitidiscaviarum isolate using the EFAE method (A) and NECLC method (B) are shown. Improved
spectra and identification scores were obtained using the NECLC approach.
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Culture of Nocardia and strains used
Bacteria were cultured on 5% sheep blood plate agar (Nip-
pon Becton Dickinson Co., Tokyo, Japan) for 3 days at 37°C.
The cultures were visually checked for purity, and typical
colonies were used to prepare samples for MALDI-TOF MS
analysis. In developing the Nocardia extraction method de-
scribed in section 3 below, a total of 10 isolates were used: 2
isolates each of N. nova, N. farcinica, N. otitidiscaviarum, N.
elegans, and N. cyriacigeorgica, all of which had been iso-
lated from clinical samples and stored at the DCLC. To con-
struct the in-house database described in section 4 below,
192 isolates from 73 species of Nocardia stored at the
MMRC were used (Table 2, Additional file 2: Table S1). For
validation of the in-house database as described in section 5
below, a total of 64 Nocardia isolates were used: 21 isolates
stored at the DCLC and 43 isolates stored at the MMRC
that were not used in construction of the in-house database
(Table 2, Additional file 2: Table S1). All of the isolates fromTable 2 A summary of the 256 Nocardia isolates used in the s
From the MMRC
Used in constructing the in-house da
No. of isolates *192
*192 isolates from the MMRC were subjected to MALDI-TOF MS analysis to construct the
the in-house database. A full detail of identity and characteristics of the 256 Nocardia iso
and used in constructing the in-house database. 43 isolates were from the MMRC and
MMRC =Medical Mycology Research Center, Chiba University.
DCLC = Department of Clinical Laboratory, Chiba University Hospital.the DCLC and almost all of the isolates from the MMRC
were isolated from clinical samples. At the DCLC and
MMRC, we typically identify Nocardia by determining
physicochemical properties, such as: the ability to
degrade organic substances such as adenine, hypoxanthine,
and tyrosine; the ability to produce acid from sugars such
as glucose, maltose, and mannose; the ability to utilize
citric acid, adipic acid, and gluconic acid; and sensitivity
to antimicrobials such as imipenem, tobramycin, and
ciprofloxacin [5]. Genetic analysis of 16S rRNA sequences
is also employed to identify all isolates mentioned above
[21-23].
MALDI biotyper system
A Microflex LT apparatus was used, with the measurement
range set at 2 to 20 kDa. FlexControl (ver. 3.3), FlexAnaly-
sis (ver. 3.3), and BioTyper (ver. 3.1) analytical software
were used, and version 3.3.1.0 of the database was used for
identification. α-CHCA (α-cyano-4-hydroxycinnamic acid)tudy
From the DCLC
tabase Used in validation
**43 **21
in-house database, whereas 64 (**43 plus **21) isolates were used for validation of
lates are shown in Additional file 2: Table S1. 192 isolates were from the MMRC
used in validation. 21 isolates were from the DCLC and used in validation.
Table 3 Validation of the NDCUH database
No. of isolates Before the NDCUH introduction After the NDCUH introduction
Species level Genus level No match Species level Genus level No match
N. abscessus 2 2 1 1
N. aobensis 2 1 1 2
N. arthritidis 2 2 1 1
N.a asiatica 3 2 1 3
N. asteroides 2 2 2
N. beijingensis 2 2 2
N. brasiliensis 2 2 2
N. concava 2 1 1 1 1
N. cyriacigeorgica 4 4 4
N. elegans 4 3 1 4
N. exalbida 2 2 2
N. farcinica 7 7 7
N. niigatensis 2 2 2
N. nova 8 5 3 7 1
N. otitidiscaviarum 3 2 1 3
N. paucivorans 1 1 1
N. pseudobrasiliensis 2 2 1 1
N. puris 3 3 3
N. transvalensis 2 1 1 1 1
N. veterana 2 1 1 2
N. vinacea 2 2 2
N. wallacei 5 5 5
Total 64 10 (15.6%) 16 (25.0%) 38 (59.4%) 58 (90.6%) 6 (9.4%) 0 (0.0%)
A total of 64 Nocardia isolates, independent of the isolates used to construct the NDCUH, were subjected to identification based on the NECLC method;
identification results before and after introduction of the NDCUH database were compared. Before the introduction, the original Bruker Biotyper ver. 3.3.1.0
database was used. In the table, the species level count indicates isolates that could be identified at both the species and genus levels; the genus level count
includes not only isolates that could be identified to the genus level but those that could not be identified to the species level.
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paratus, software, reagents, and database were all products
of Bruker Daltonics). The process from MALDI-TOF MS
measurement to identification was described in a previous
report [7]. In brief, the process was performed automatic-
ally without user intervention using the manufacturer’s de-
fault settings. The software generated a list of peaks,
numbering up to 100. The threshold for peak acceptance
was a signal to noise ratio of 10. After alignment, peaks
with a mass to charge ratio difference of less than 250 ppm
were considered to be identical. The peak list was used for
matching against the reference library by direct use of the
integrated pattern matching algorithm of the software. Re-
sults for the pattern-matching process were expressed as
scores ranging from 0 to 3, as suggested by the manufac-
turer. Scores of <1.7 were not considered to provide reli-
able identification. A score of ≥1.7 indicated identification
of at the genus level, and a score of ≥2.0 indicated identifi-
cation of at the species level [7].Development of the Nocardia extraction method at DCLC
(NECLC)
The processes used in the EFAE for general bacteria and
the HTEM used for acid-fast bacteria are shown in
Figures 1A and 1B. To enable bacterial identification using
MALDI-TOF MS, extraction methods have been developed
for two decades [20,24,25]. The EFAE method [25] is a sim-
ple universal method recommended by the manufacturer
for the extraction of general bacteria. The HTEM method
[20] is also recommended by the manufacturer for the pro-
cessing of acid-fast bacteria. To assess the effects of silica
beads (Zirconia/Silica Beads 0.5 mm dia; Bio Spec Products
inc, USA) used in the attempt to improve the effectiveness
of bacterial cell disruption, beads were added during sample
extraction in the EFAE method. A 1-μL aliquot of sample
was placed on the target plate, dried, overlaid with 1-μL of
α-CHCA matrix and dried again, after which the target
plate was placed in the MALDI-TOF MS, analyzed, and the
changes in identification scores were evaluated. As shown
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S2, better scores were obtained with the addition of silica
beads.
Next, to determine whether to use beads for the EFAE
or HTEM method, sample extraction was performed using
both methods following the procedures described above,
and changes in the identification scores were evaluated.
As shown in Additional file 5: Figures S2, Additional file 6:
Figures S3 and Additional file 2: Table S3 better scores
were obtained when using beads with the EFAE method.
To investigate the effect of varying the duration of for-
mic acid extraction, we extracted samples for 1, 5, and
10 minutes using the same procedures described above
and evaluated changes in the identification scores. As
shown in Additional file 7: Figure S4 and Additional
file 2: Table S4, the best scores were obtained at a for-
mic acid extraction time of 10 minutes.
Based upon all of the above results, we proposed a new
method for the extraction of Nocardia (the Nocardia ex-
traction method in the Department of Clinical Laboratory
at Chiba University Hospital; NECLC) (Figure 1C).
Constructing the in-house database
Samples were extracted from the MMRC’s 192 Nocardia
isolates using the proposed NECLC approach. The samples
were plated (1 μL per site) on 8 sites on the target plate,
and after drying, 1 μL of α-CHCA matrix was overlaid
onto each sample and then dried. The target plate was
placed in the MALDI-TOF MS and each site was analyzed
3 times; thus, with 8 sites, this enabled collection of 24
mass spectra per sample. The resulting data were averaged
with FlexControl, and a single mass spectrum representing
each sample was generated. The NDCUH was constructed
by compiling mass spectra produced by employing this
method on 192 isolates and adding these to the manufac-
turer’s database used for identification as described in sec-
tion 2 above. Cluster analysis was performed to investigate
differences in spectra between strains in the version 3.3.1.0
database and the MMRC’s 192 isolates. The BioTyper (ver.
3.1) software was used to conduct the cluster analysis.
Validation of the in-house database
Samples were extracted from 64 Nocardia isolates (43
isolates from the MMRC and 21 isolates from the
DCLC) using the proposed NECLC approach, and mass
spectra were then collected. Pattern matching was per-
formed based on each mass spectrum in reference to the
NDCUH database, and identification scores before and
after introduction of the in-house database were evalu-
ated for improvement.
Statistical methods
Identification scores are presented in Table 1 as the
mean ± SD (standard deviation). The results were analyzedusing the paired t test for comparisons to determine the
significance of differences using the 4-Step Excel Statistics
software application (OMS Publishing Inc., Tokorozawa,
Japan; http://www.oms-publ.co.jp/index.html). Significance
levels were set at a P value < 0.05.
Additional files
Additional file 1: Figure S5. A spectra-based dendrogram of the
manufacturer’s database strains and the 192 MMRC Nocardia isolates. The
BioTyper (ver. 3.1) software was used to perform a cluster analysis and
draw the dendrogram. The manufacturer’s database strains are displayed
in red, and the MMRC isolates are displayed in black.
Additional file 2: Table S1. A full detail of identity and characteristics
of the 256 Nocardia isolates used in the study. Table S2. Improvement in
the identification score by incorporating silica beads. Table S3.
Comparison of identification scores from specimens extracted using the
ethanol-formic acid extraction method (EFAE) and high-temperature
extraction (HTEM) method.
Additional file 3: Figure S6. Representative improvement in mass
spectra matching and identification scores using the newly developed
extraction method (NECLC) and the in-house database (NDCUH) to
identify the same isolates (N. nova, N. elegans). With the introduction of the
NECLC method and NDCUH database, the identification score for N. nova
increased (A), and N. elegans, a strain that was previously unidentifiable,
could now be identified to the species level (B). This figure shows matching
between the spectrum collected and a reference spectrum stored in the
database. Blue indicates the spectrum stored in the database used for
pattern matching; in the upper half of the spectrum, green indicates
matched peaks, red mismatched peaks, and yellow intermediate peaks.
Additional file 4: Figure S1. Comparison of representative mass
spectra obtained from extraction with and without silica beads (N.
otitidiscaviarum isolate). Identification scores determined from each
spectrum are indicated.
Additional file 5: Figure S2. Comparison of representative mass
spectra and identification scores for the same isolate extracted using the
HTEM and EFAE methods (N. farcinica isolate). Specimens extracted using
either the ethanol-formic acid extraction method (EFAE) or the high-
temperature extraction method (HTEM) are compared.
Additional file 6: Figure S3. Comparison of representative mass spectra
and identification scores for the same isolate extracted using the HTEM and
EFAE methods (N. cyriacigeorgica isolate). Specimens extracted using either
the ethanol-formic acid extraction method (EFAE) or the high-temperature
extraction method (HTEM) are compared. A baseline rise due to noise was
observed between 2,000 to 6000 m/z when the isolate was extracted using
the HTEM method, and circled by red line (A). On the other hand, such rise
was not observed when using the EFAE method (B). Each mass spectra
matching between the spectrum collected and a reference spectrum stored
in the database is indicated at the right top corner of each raw spectrum.
Blue indicates the spectrum stored in the database used for pattern
matching; in the upper half of the spectrum, green indicates matched peaks,
red mismatched peaks, and yellow intermediate peaks. Like the baseline
noise, mismatched peaks were observed between 2,000 to 6000 m/z when
the isolate was extracted using the HTEM method, which may result in a
decrease of identification score.
Additional file 7: Figure S4. Comparison of representative mass spectra
and identification scores for different extraction durations using the EFAE
method. Extraction durations of 1, 5, and 10 minutes in the EFAE
(ethanol-formic acid extraction) method were tested with the same N. nova
isolate.
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